Infant formulas lack the complex mixture of oligosaccharides found in human milk. These human milk oligosaccharides (HMO) may be pivotal to the development of the neonatal immune system. Few comprehensive analyses of the effects of HMO on immune cells from neonates have been undertaken. Herein, the direct effects of HMO on immune cells were analysed ex vivo. Peripheral blood mononuclear cells (PBMC) isolated from 10-d-old sow-reared (SR) or colostrum-deprived formula-fed (FF) pigs were stimulated for 72 h with single HMO, mixtures of single HMO or a complex mixture of HMO isolated from human milk (iHMO). T-cell phenotype, cytokine production and proliferation were measured by flow cytometry, immunoassay and [ 3 H]thymidine incorporation, respectively. Stimulation with HMO had direct effects on PBMC. For instance, cells stimulated with iHMO produced more IL-10 than unstimulated cells, and cells stimulated with fucosylated HMO tended to proliferate less than unstimulated cells. Additionally, co-stimulation with HMO mixtures or single HMO altered PBMC responses to phytohaemagglutinin (PHA) or lipopolysaccharide (LPS) stimulation. Compared with PBMC stimulated with PHA alone, cells co-stimulated with iHMO and PHA proliferated more and had fewer detectable CD4 þ CD8 þ T cells. Compared with PBMC stimulated by LPS alone, cells co-stimulated with a mixture of sialylated HMO and LPS proliferated more and tended to have fewer detectable CD4 þ T cells. Differences in the baseline responses of PBMC isolated from the SR or FF pigs were observed. In summary, HMO directly affected PBMC populations and functions. Additionally, ex vivo measurements of PBMC phenotype, cytokine production and proliferation were influenced by the neonate's diet.Key words: Infants: Human milk: Oligosaccharides: Immunity: Pigs Immune response, as evidenced by the differences in the rates of infection (1 -6) and vaccination response (6,7) , differs between breast-fed (BF) and formula-fed (FF) human infants. This difference may be due in part to dissimilarities in the composition of infant formulas and human milk. Cow milk-based formulas are devoid of many of the bioactive components that are present in human milk, including human milk oligosaccharides (HMO) (reviewed in Kunz et al. (8) ). The complexity and quantity of oligosaccharides are unique to human milk. For example, after lactose and fat, HMO constitute the third most abundant component of human milk (10-15 g/l). Furthermore, up to 200 potential oligosaccharide structures have been identified in human milk, of which typically approximately 70 % are fucosylated (8,9) . In contrast, cows' milk contains less than 0·1 g oligosaccharides/l milk (8,9) , and much less structural diversity (forty structures) and very few fucosylated oligosaccharides (10) . Accordingly, structurally complicated oligosaccharides are rare in cow milk-based infant formulas and, thus, constitute a major compositional difference in the diets of BF infants compared with FF infants.Oligosaccharides are important wit...